Literature DB >> 15090362

MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy.

Michèl A A P Willemsen1, Marinette Van Der Graaf, Marjo S Van Der Knaap, Arend Heerschap, Peter H M F Van Domburg, Fons J M Gabreëls, Jan J Rotteveel.   

Abstract

BACKGROUND AND
PURPOSE: Sjögren-Larsson syndrome (SLS) is a neurocutaneous syndrome caused by a genetic enzyme deficiency in lipid metabolism. Our purpose was to characterize the nature of the cerebral involvement in SLS.
METHODS: MR imaging was performed in 18 patients (aged 5 months to 45 years) and repeated in 14. Single-voxel proton MR spectra were acquired from cerebral white matter and gray matter in 16 patients, with follow-up studies in 11. LCModel fits were used to determine brain metabolite levels.
RESULTS: MR imaging showed retardation of myelination and a mild persistent myelin deficit. A zone of increased signal intensity was seen in the periventricular white matter on T2-weighted images. Proton MR spectroscopy of white matter revealed a prominent peak at 1.3 ppm, normal levels of N-acetylaspartate, and elevated levels of creatine (+14%), choline (+18%), and myo-inositol (+54%). MR imaging and proton MR spectroscopy of gray matter were normal. In the two patients examined during the first years of life, abnormalities on MR imaging and proton MR spectroscopy gradually emerged and then stabilized, as in all other patients.
CONCLUSION: Abnormalities on MR imaging and proton MR spectroscopy emerge during the first years of life and are similar in all patients with SLS, but the severity varies. The changes are confined to cerebral white matter and suggest an accumulation of lipids, periventricular gliosis, delayed myelination, and a mild permanent myelin deficit.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090362      PMCID: PMC7975598     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  36 in total

1.  MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata.

Authors:  Angèle Viola; Sylviane Confort-Gouny; Jean-Philippe Ranjeva; Brigitte Chabrol; Charles Raybaud; Francisca Vintila; Patrick J Cozzone
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

2.  Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization.

Authors:  T L Kelson; J R Secor McVoy; W B Rizzo
Journal:  Biochim Biophys Acta       Date:  1997-04-17

3.  Oligophrenia in combination with congenital ichthyosis and spastic disorders; a clinical and genetic study.

Authors:  T SJOGREN; T LARSSON
Journal:  Acta Psychiatr Neurol Scand Suppl       Date:  1957

4.  Sjögren-Larsson syndrome: postmortem brain abnormalities.

Authors:  K Yamaguchi; T Handa
Journal:  Pediatr Neurol       Date:  1998-04       Impact factor: 3.372

5.  Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders.

Authors:  H Bruhn; B Kruse; G C Korenke; F Hanefeld; W Hänicke; K D Merboldt; J Frahm
Journal:  J Comput Assist Tomogr       Date:  1992 May-Jun       Impact factor: 1.826

6.  Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sj-ogren-Larsson syndrome.

Authors:  P F James; R A Zoeller
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

7.  Pathology of the Sjögren-Larsson syndrome.

Authors:  H S Baar; J Galindo
Journal:  J Maine Med Assoc       Date:  1965-10

8.  Monoaminergic dysfunction in Sjögren-Larsson syndrome.

Authors:  P Wester; U Bergström; A Brun; S Jagell; B Karlsson; A Eriksson
Journal:  Mol Chem Neuropathol       Date:  1991-08

9.  Cerebral MRI and spectroscopy in Sjögren-Larsson syndrome: case report.

Authors:  Y Miyanomae; M Ochi; H Yoshioka; K Takaya; Z Kizaki; F Inoue; S Furuya; S Naruse
Journal:  Neuroradiology       Date:  1995-04       Impact factor: 2.804

10.  Neuropathological correlation in Sjögren-Larsson syndrome. Oligophrenia, ichthyosis and spasticity.

Authors:  J E McLennan; F H Gilles; R M Robb
Journal:  Brain       Date:  1974-12       Impact factor: 13.501

View more
  27 in total

1.  A novel assay for the prenatal diagnosis of Sjögren-Larsson syndrome.

Authors:  D M van den Brink; J M van Miert; R J A Wanders
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 2.  Recognition and diagnosis of neuro-ichthyotic syndromes.

Authors:  William B Rizzo; Sabrina Malone Jenkens; Philip Boucher
Journal:  Semin Neurol       Date:  2012-03-15       Impact factor: 3.420

Review 3.  Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.

Authors:  William B Rizzo
Journal:  Mol Genet Metab       Date:  2006-09-22       Impact factor: 4.797

Review 4.  Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.

Authors:  Ana R Malheiro; Tiago Ferreira da Silva; Pedro Brites
Journal:  J Inherit Metab Dis       Date:  2014-11-29       Impact factor: 4.982

5.  Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes.

Authors:  Kathleen Davis; Kenton R Holden; Dana S'Aulis; Claudia Amador; M Gisele Matheus; William B Rizzo
Journal:  J Child Neurol       Date:  2012-10-03       Impact factor: 1.987

6.  Detection and characterization of neurotoxicity in cancer patients using proton MR spectroscopy.

Authors:  Emilie A Steffen-Smith; Pamela L Wolters; Paul S Albert; Eva H Baker; Kim C Shimoda; Alan S Barnett; Katherine E Warren
Journal:  Childs Nerv Syst       Date:  2008-02-22       Impact factor: 1.475

7.  Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.

Authors:  Ujjawal Roy; Urmila Das; Alak Pandit; Anjan Debnath
Journal:  BMJ Case Rep       Date:  2016-04-19

8.  Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.

Authors:  William B Rizzo; Dana S'Aulis; M Anitia Jennings; Debra A Crumrine; Mary L Williams; Peter M Elias
Journal:  Arch Dermatol Res       Date:  2010-01-05       Impact factor: 3.017

Review 9.  In vivo magnetic resonance spectroscopy: basic methodology and clinical applications.

Authors:  Marinette van der Graaf
Journal:  Eur Biophys J       Date:  2009-08-13       Impact factor: 1.733

10.  Sjögren-Larsson syndrome in two brothers: a case report.

Authors:  Farid Rezaei Moghaddam; Farid Safar; Mahsa Asheghan; Zahra Reza Soltani; Fatemeh Dehghani Zade
Journal:  Cases J       Date:  2009-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.